STADA Arzneimittel AG

Focus on markets with high structural growth potential

Worldwide, STADA has for many years been successfully active in health care markets which are characterized by significant growth and earnings opportunities. In the scope of the strategic positioning “STADA – The Health Company”, STADA focuses on the two core segments1) Generics and Branded Products. In view of costs and risks, STADA deliberately does not conduct any own research, but focuses on products with off-patent active ingredients, so called “multisource products”, that are readily available. This makes it possible for the Group to offer a majority of its products as low-priced generics. International sales infrastructure

An essential factor for success of the STADA business model is market proximity through the international network of local sales companies. Only through its local sales presence in the individual national markets, which due to the different health care systems differ strongly, is the Group capable to take advantage of the respective structural growth potential for its own growth. In order to rapidly accommodate the frequent variations in structural conditions of the respective national health care markets, the local STADA sales companies have a high level of sales autonomy. In individual national markets, STADA thereby also relies on sales companies which operate parallel to oneanother or focus on specific market segments if the respective market structures require this to take optimal advantage of the potential.